Crossmark

Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis

Crossref DOI link: https://doi.org/10.1186/s13613-018-0353-2

Published Print: 2018

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Annane, Djillali

Mira, Jean-Paul

Ware, Lorraine B.

Gordon, Anthony C.

Hinds, Charles J.

Christiani, David C.

Sevransky, Jonathan

Barnes, Kathleen

Buchman, Timothy G.

Heagerty, Patrick J.

Balshaw, Robert

Lesnikova, Nadia

de Nobrega, Karen

Wellman, Hugh F.

Neira, Mauricio

Mancini, Alexandra D.J.

Walley, Keith R.

Russell, James A.
Funding

Funding for this research was provided by:

SIRIUS GENOMICS INC
License Information

Text and Data Mining valid from 2018-01-01

Text and Data Mining valid from 2018-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-018-0353-2

Content Type: article

Copyright: Copyright © 2018 The Author(s) 2018. Published by Elsevier Masson SAS